𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors

✍ Scribed by Grimes, J.; Celler, A.; Birkenfeld, B.; Shcherbinin, S.; Listewnik, M. H.; Piwowarska-Bilska, H.; Mikolajczak, R.; Zorga, P.


Book ID
111889876
Publisher
The Society of Nuclear Medicine
Year
2011
Tongue
English
Weight
447 KB
Volume
52
Category
Article
ISSN
0161-5505

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Radiopharmaceutical development of a fre
✍ Elisabeth Von Guggenberg; Renata Mikolajczak; Barbara Janota; Georg Riccabona; C πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 150 KB

99m Tc-EDDA-HYNIC-D-Phe 1 ,Tyr 3 ]-Octreotide ( 99m Tc-EDDA/HYNIC-TOC) is a promising new radiopharmaceutical with the potential to replace [ 111 In-DTPA-D-Phe 1 ]-Octreotide ( 111 In-DTPA-OCT) as the radiopharmaceutical for somatostatin receptor scintigraphy due to the advantage of improved image